Profile and costs of dengue hospitalizations in Southeast Pará from the SUS perspective (2000-2015)
DOI:
https://doi.org/10.17058/reci.v12i1.17269Abstract
Background and objectives: Considering the little evidence associated with dengue hospitalizations, their public expenditures in Southeast Pará and its relevance to the public health in Brazil, this study aims to demonstrate the records of hospitalizations and expenses associated with this arbovirus between 2000 and 2015 from the perspective of the Unified Health System (SUS). Methods: This is a descriptive research that sought to assess the records and expenses (USD) of hospitalization caused by dengue (SUS code: 74500457, 74300440, 0303010010) and severe dengue (SUS code: 74300628, 74500627, 0303010029), as well as their associated deaths (CID: A90 and A91), respectively, from the SIH/SUS and SIM/SUS from 2000 to 2015 for all 39 municipalities in the southeast of Pará. Results: A total of 1206 deaths, 22,860 individuals with dengue and 306 with severe dengue underwent services in the SUS between 2000 and 2015, representing 23,166 hospitalizations (23,613: dengue and 313: severe dengue), in which Bom Jesus do Tocantins and Goianésia do Pará represent the municipalities with the highest number of hospitalizations associated with dengue. Conclusion: It is possible to verify the relevance of continuing efforts to combat and fight dengue in southeastern Pará. It reinforces the need to conduct studies that contribute to a better understanding of the distribution of hospitalizations and deaths in the different municipalities of the state of Pará, as well as reflections on the epidemiological and economic scenario for the implementation of a rational and efficient decision-making process.
Downloads
References
WHO. Dengue and severe dengue, 2021. https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue
Ministério da Saúde (BR). Portaria nº 204, de 17 de fevereiro de 2016. https://bvsms.saude.gov.br/bvs/saudelegis/gm/2016/prt0204_17_02_2016.html
Cegolon L, Heymann WC, Lange JH. Definitive tests for dengue fever: when and which should I use? Singapore Med J. 2018; 59(3): 165. https://doi.org/10.11622/smedj.2018031
Ministério da Saúde (BR). Dengue diagnóstico e manejo clínico de adultos e crianças. 2016b. https://portaldeboaspraticas.iff.fiocruz.br/biblioteca/dengue-diagnostico-e-manejo-clinico-adulto-e-crianca/
OPAS. Dengue, 2021. https://www.paho.org/pt/topicos/dengue?page=1
Luz LM, Rodrigues JEC, Ponte FC et al. Atlas Geográfico Escolar do Estado do Pará. 1. ed. - Belém: GAPTA/UFPA, 2013.
Instituto Oswaldo Cruz. Dengue vírus e vetor: longa trajetória, 2022. http://www.ioc.fiocruz.br/dengue/textos/longatraje.html
Dourado JM, Araújo CS, Godói IP. Hospitalizações, óbitos e gastos com dengue entre 2000 e 2015 na região norte do Brasil. Revista Brasileira Interdisciplinar de saúde. 2020; 2:32-39. https://revistarebis.rebis.com.br/index.php/rebis/article/view/126
Morais MV, de Andrade CR, da Silva GH et al. Epidemiological Impact and Hospitalization costs applied to dengue in the Midwest region of Minas Gerais state, Brazil, from SUS perspective. J Vector Borne Dis. 2020.; 57: 331-40. https://www.jvbd.org/article.asp?issn=0972-9062;year=2020;volume=57;issue=4;spage=331;epage=340;aulast=Morais
Godói IP, Silva LV, Sarker AR et al. Economic and epidemiological impact of dengue illness over 16 years from a public health system perspective in Brazil to inform future health policies including the adoption of a dengue vaccine. Journal Expert Review Of Vaccines. 2018. 17 (12): 1123-33. https://doi.org/10.1080/14760584.2018.1546581
DataSUS. [BR]; 2021a.População Residente – Pará 2021.http://tabnet.datasus.gov.br/cgi/deftohtm.exe?ibge/cnv/poppa.def
FAPESP. [BR]. Anuário Estatístico do Pará 2019. População e Estimativas Populacionais, Pará e municípios – 2014 a 2018. 2019. https://www.fapespa.pa.gov.br/sistemas/anuario2019/tabelas/demografia/tab-1.1-populacao-total-e-estimativas-populacionais-2014-a-2018.htm
WHO. Dengue and Severe Dengue, 2022. https://www.who.int/en/news-room/fact-sheets/detail/dengue-and-severe-dengue
Araújo CS, Godói IPD. Avaliação de Banco de Dados em Saúde: Impacto Econômico e Epidemiológico da Dengue na Região Norte do Brasil. 2020. https://sic.unifesspa.edu.br/images/SIC2020/Artigos/submissao_16021870195391602697986632.pdf
Carmo RF, Silva Júnior JVJ, Pastor AF et al. Spatiotemporal dynamics, risk areas and social determinants of dengue in Northeastern Brazil, 2014–2017: an ecological study. Infect Dis Poverty. 2020; 153(9):1-16. https://doi.org/10.1186/s40249-020-00772-6
Sousa SC, Carneiro M, Eiras AE et al. Factors associated with the occurrence of dengue epidemics in Brazil: a systematic review. Rev Panam Salud Publica. 2021; 45:1-8. https://doi.org/10.26633/RPSP.2021.84
Pereira MG. O clima tropical e a dengue. Uma análise como subsídio para gestão ambiental Municipal, Belém. Universidade Federal do Pará. 2016. http://www.repositorio.ufpa.br/jspui/bitstream/2011/10317/1/Dissertacao_ClimaTropicalDengue.pdf
Teich V, Arinelli R, Fahham L. Aedes aegypti e sociedade: o impacto econômico das arboviroses no Brasil. J Bras Econ Saúde. 2017; 9 (3): 267-276. https://doi.org/10.21115/JBES.v9.n3.p267-76.
Godói IP, Lemos LLP, Araújo VE et al. CYD-TDV dengue vaccine: systematic review and meta-analysis of efficacy, immunogenicity and safety. J Comp Eff Res. 2017;6(2):165–180. https://doi.org/10.2217/cer-2016-0045
WHO. Vaccines and immunization: Dengue, 2018. https://www.who.int/news-room/questions-and-answers/item/dengue-vaccines
Teixeira MG, Costa MCN, Paixão ES et al. The achievements of the SUS in tackling the communicable diseases. Ciênc saúde colet. 2018; 23 (6): 1819-1828. https://www.scielo.br/j/csc/a/qQCnB7Fb4w6NwYQrHFzbmPL/?format=pdf&lang=en
Godói IP, Santos AS, Reis EA et al. Consumer Willingness to Pay for Dengue Vaccine (CYDTDV, Dengvaxia R) in Brazil; Implications for Future Pricing Considerations. Frontier Pharmacol. 2017; 8(41):1-9.https://doi.org/10.3389/fphar.2017.00041
Araújo VEM, Bezerra JMT, Amâncio FF et al. Aumento da carga de dengue no Brasil e unidades federadas, 2000 e 2015: análise do Global Burden of Disease Study. Rev Bras Epidemiologia. 2017; 20:205-16. https://doi.org/10.1590/1980-5497201700050017
Ministério da Saúde. [BR]; 2021b. Vacinação: quais as vacinas, para que servem, por que vacinar, mitos. http://cosemsma.org.br/2019/10/vacinacao-quais-sao-as-vacinas-para-que-servem-por-que-vacinar-mitos/
ABRASCO [BR]; 2018. Posicionamento da Abrasco sobre a vacina DENGVAXIA®.https://www.abrasco.org.br/site/noticias/posicionamentos-oficiais-abrasco/vacinacacao-dengue-parana/32761/
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Juliana Mota Salgado, Thannuse Silva Athie, Gabriel Henrique da Silva, William Gustavo Lima, Isabella Piassi Dias Godói
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author must state that the paper is original (has not been published previously), not infringing any copyright or other ownership right involving third parties. Once the paper is submitted, the Journal reserves the right to make normative changes, such as spelling and grammar, in order to maintain the language standard, but respecting the author’s style. The published papers become ownership of RECI, considering that all the opinions expressed by the authors are their responsibility. Because we are an open access journal, we allow free use of articles in educational and scientific applications provided the source is cited under the Creative Commons CC-BY license.
